Sign in

CIK 0001504776

  • Large accelerated filer

Warby Parker Inc.

Sign in to watch
Ticker
WRBY
Exchange
NYSE
Industry
Ophthalmic Goods
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
800423634
Phone
+1 646-847-7215
Business address
233 SPRING STREET, 6TH FLOOR EAST, NEW YORK, NY, 10013
Former names
JAND, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,861,485
in 5 filings, $7.9M under 10b5-1 plans

Net −$7,861,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-06-07 Miller Steven Clive Chief Financial Officer Exercise or conversion 10b5-1 +26,511 193,390
2024-06-07 Miller Steven Clive Chief Financial Officer Sale 10b5-1 −10,984 $16.67 $183K 182,406
2024-06-07 Miller Steven Clive Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −58,455 0
2024-06-07 Miller Steven Clive Chief Financial Officer Exercise or conversion · Restricted Stock Units 10b5-1 −8,880 94,717
2024-06-07 Miller Steven Clive Chief Financial Officer Exercise or conversion · Restricted Stock Units 10b5-1 −5,096 23,781
2024-06-07 Miller Steven Clive Chief Financial Officer Exercise or conversion · Restricted Stock Units 10b5-1 −1,981 5,283
2024-06-07 Miller Steven Clive Chief Financial Officer Exercise or conversion · Restricted Stock Units 10b5-1 −10,554 154,798
2024-06-06 Miller Steven Clive Chief Financial Officer Exercise or conversion 10b5-1 +10,601 $13.08 $139K 181,926
2024-06-06 Miller Steven Clive Chief Financial Officer Exercise or conversion 10b5-1 +662 $12.35 $8K 182,588
2024-06-06 Miller Steven Clive Chief Financial Officer Sale 10b5-1 −15,709 $17.04 $268K 166,879
2024-06-06 Miller Steven Clive Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −10,601 0
2024-06-06 Miller Steven Clive Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −662 58,455
2024-03-11 Miller Steven Clive Chief Financial Officer Sale 10b5-1 −24,225 $11.98 $290K 166,879
2024-03-08 Gilboa David Abraham Co-Chief Executive Officer Conversion 10b5-1 +52,065 64,371
2024-03-08 Gilboa David Abraham Co-Chief Executive Officer Sale 10b5-1 −52,065 $12.20 $635K 12,306
2024-03-08 Gilboa David Abraham Co-Chief Executive Officer Conversion · Class B Common Stock 10b5-1 −52,065 6,615,635
2024-03-07 Blumenthal Neil Harris Co-Chief Executive Officer Conversion 10b5-1 +50,000 62,177
2024-03-07 Blumenthal Neil Harris Co-Chief Executive Officer Sale 10b5-1 −50,000 $12.40 $620K 12,177
2024-03-07 Blumenthal Neil Harris Co-Chief Executive Officer Conversion · Class B Common Stock 10b5-1 −50,000 4,226,641
2024-03-06 Gilboa David Abraham Co-Chief Executive Officer Conversion 10b5-1 +28,311 40,617

Page 22 of 59 · 1,167 trades